Literature DB >> 22189924

The impact of a history of psychotic symptoms on cognitive function in euthymic bipolar patients: a comparison with schizophrenic patients and healthy controls.

Sofia Brissos1, Vasco Videira Dias, Márcio Gerhardt Soeiro-de-Souza, Vicent Balanzá-Martínez, Flavio Kapczinski.   

Abstract

BACKGROUND: About two-thirds of patients with bipolar disorder (BD) have a lifetime history of at least one psychotic symptom.
OBJECTIVE: To compare the neurocognitive performance of four groups: BD patients with and without a history of psychotic symptoms (BD HPS+ and BD HPS-, respectively); patients with schizophrenia (SZ); and healthy control (HC) subjects.
METHOD: In this cross-sectional study, 35 stabilized patients with SZ, 79 euthymic (44 HPS+ and 35 HPS-) patients with BD, and 50 HC were administered a comprehensive battery of neuropsychological tests.
RESULTS: There was worse neurocognitive functioning in both BD and SZ patients compared to HC. Overall, data from both groups of BD patients did not differ on sociodemographic, clinical, or neurocognitive variables. However, BD HPS+ patients had significantly more negative symptoms, as measured by the Positive and Negative Syndrome Scale (PANSS), and showed a trend toward worse performance on executive functions compared to BD HPS- patients. Moreover, both BD groups had better performance on all neurocognitive tests compared to SZ group.
CONCLUSIONS: Neurocognitive dysfunction may be more marked in SZ than in BD, yet qualitatively similar. A history of past psychotic symptoms in BD was not associated with more severe cognitive impairment during euthymia. Therefore, BD with psychotic symptoms does not appear to be a distinct neurocognitive phenotype.

Entities:  

Mesh:

Year:  2011        PMID: 22189924     DOI: 10.1590/s1516-44462011000400008

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN: 1516-4446            Impact factor:   2.697


  7 in total

Review 1.  Neurocognitive functioning in euthymic patients with bipolar disorder and unaffected relatives: A review of the literature.

Authors:  Stephanie A Cardenas; Layla Kassem; Melissa A Brotman; Ellen Leibenluft; Francis J McMahon
Journal:  Neurosci Biobehav Rev       Date:  2016-08-05       Impact factor: 8.989

Review 2.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

3.  Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study.

Authors:  S Kristian Hill; James L Reilly; Michael E Ragozzino; Leah H Rubin; Jeffrey R Bishop; Ruben C Gur; Elliot S Gershon; Carol A Tamminga; Godfrey D Pearlson; Matcheri S Keshavan; Richard S E Keefe; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-09-05       Impact factor: 9.306

Review 4.  Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates.

Authors:  Vicent Balanzá-Martínez; Benedicto Crespo-Facorro; Ana González-Pinto; Eduard Vieta
Journal:  Front Physiol       Date:  2015-04-07       Impact factor: 4.566

5.  Impairments of working memory in schizophrenia and bipolar disorder: the effect of history of psychotic symptoms and different aspects of cognitive task demands.

Authors:  Dorota Frydecka; Abeer M Eissa; Doaa H Hewedi; Manal Ali; Jarosław Drapała; Błażej Misiak; Ewa Kłosińska; Joseph R Phillips; Ahmed A Moustafa
Journal:  Front Behav Neurosci       Date:  2014-11-28       Impact factor: 3.558

6.  Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment.

Authors:  Wenhao Zhu; Hao Huang; Shiqi Yang; Xiang Luo; Wenzhen Zhu; Shabei Xu; Qi Meng; Chengchao Zuo; Yong Liu; Wei Wang
Journal:  Neurosci Bull       Date:  2021-04-07       Impact factor: 5.203

7.  Cognitive impairment in bipolar disorder and schizophrenia: a systematic review.

Authors:  Paul A Vöhringer; Sergio A Barroilhet; Andrea Amerio; Maria Laura Reale; Katherine Alvear; Derick Vergne; S Nassir Ghaemi
Journal:  Front Psychiatry       Date:  2013-08-08       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.